Epstein-Barr virus+ B cells in breast cancer immune response: a case report

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Aran, Andrea
• dc.contributor.author Peg, Vicente
• dc.contributor.author Rabanal, Rosa María
• dc.contributor.author Bernadó, Cristina
• dc.contributor.author Zamora, Esther
• dc.contributor.author Molina, Elisa
• dc.contributor.author Arribas, Yago A.
• dc.contributor.author Arribas, Joaquín
• dc.contributor.author Pérez, José
• dc.contributor.author Roura-Mir, Carme
• dc.contributor.author Carrascal, Montserrat
• dc.contributor.author Cortés, Javier
• dc.contributor.author Martí, Mercè
• dc.date.accessioned 2022-07-28T07:11:35Z
• dc.date.available 2022-07-28T07:11:35Z
• dc.date.issued 2021
• dc.description.abstract EBV-specific T cells have been recently described to be involved in fatal encephalitis and myocarditis in cancer patients after immune checkpoint therapies. Here, we report the study of a human triple-negative breast cancer tumor (TNBC) and EBV-transformed B cells obtained from a patient-derived xenograft (PDX) that progressed into a lymphocytic neoplasm named xenograft-associated B-cell lymphoma (XABCL). T-cell receptor (TCR) high-throughput sequencing was performed to monitor the T-cell clonotypes present in the different samples. Forty-three T-cell clonotypes were found infiltrating the XABCL tissue after three passes in mice along 6 months. Eighteen of these (42%) were also found in the TNBC biopsy. TCR infiltrating the XABCL tissue showed a very restricted T-cell repertoire as compared with the biopsy-infiltrating T cells. Consequently, T cells derived from the TNBC biopsy were expanded in the presence of the B-cell line obtained from the XABCL (XABCL-LCL), after which the TCR repertoire obtained was again very restricted, i.e., only certain clonotypes were selected by the B cells. A number of these TCRs had previously been reported as sequences involved in infection, cancer, and/or autoimmunity. We then analyzed the immunopeptidome from the XABCL-LCL, to identify putative B-cell-associated peptides that might have been expanding these T cells. The HLA class I and class II-associated peptides from XABCL-LCL were then compared with published repertoires from LCL of different HLA typing. Proteins from the antigen processing and presentation pathway remained significantly enriched in the XABCL-LCL repertoire. Interestingly, some class II-presented peptides were derived from cancer-related proteins. These results suggest that bystander tumor-infiltrating EBV+ B cells acting as APC may be able to interact with tumor-infiltrating T cells and influence the TCR repertoire in the tumor site.
• dc.description.sponsorship This project was funded by Roche Farma, S.A. grant SP181123001 and the Spanish Ministry of Science, Innovation and Universities grant RTI2018-097414-B-I00. Partial financial support was received from the “El Paseíco de la Mama” 2015. This study received partial funding from Roche Farma, S.A. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication.
• dc.format.mimetype application/pdf
• dc.identifier.citation Aran A, Peg V, Rabanal RM, Bernadó C, Zamora E, Molina E, et al. Epstein-Barr virus+ B cells in breast cancer immune response: a case report. Front Immunol. 2021 Nov 16; 12: 761798. DOI: 10.3389/fimmu.2021.761798
• dc.identifier.doi http://dx.doi.org/10.3389/fimmu.2021.761798
• dc.identifier.issn 1664-3224
• dc.identifier.uri http://hdl.handle.net/10230/53871
• dc.language.iso eng
• dc.publisher Frontiers
• dc.relation.projectID info:eu-repo/grantAgreement/ES/2PE/RTI2018-097414-B-I00
• dc.rights Copyright © 2021 Aran, Peg, Rabanal, Bernadó, Zamora, Molina, Arribas, Arribas, Pérez, Roura-Mir, Carrascal, Cortés and Martí. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) http://creativecommons.org/licenses/by/4.0/. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword B cells
• dc.subject.keyword Epstein–Barr virus
• dc.subject.keyword T cells
• dc.subject.keyword TCR—T-cell receptor
• dc.subject.keyword Breast cancer
• dc.title Epstein-Barr virus+ B cells in breast cancer immune response: a case report
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion